🕵️ ARS Pharmaceuticals, Inc. ($SPRY)
SEC insider & ownership activity, last 12 months · CIK 1671858 · every row links its SEC filing
Over the last 12 months insiders sold $3.6M with no open-market buying against it. Justin Chakma sold $1.5M in discretionary trades (Nov). James E. Flynn trimmed 8.8% → 7.8%; Deerfield Management Company, L.P. trimmed 8.8% → 7.8%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 7 sellers, $3.6M (9 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Justin Chakma | 0 | – | 2 | $1.5M | Nov 12, 2025 |
| Richard E. Lowenthal | 0 | – | 1 | $724K | Aug 21, 2025 |
| Tanimoto Sarina | 0 | – | 2 | $704K | Aug 20, 2025 |
| Eric Karas | 0 | – | 1 | $250K | Jun 12, 2026 |
| Brian T Dorsey | 0 | – | 1 | $190K | Nov 13, 2025 |
| Kathleen D. Scott | 0 | – | 1 | $188K | Aug 21, 2025 |
| Alexander Fitzpatrick | 0 | – | 1 | $34K | Jun 12, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 11.1% | 13D | Sep 29, 2025 | filing ↗ | |
| Peter Kolchinsky | 11.1% | 13D | Sep 29, 2025 | filing ↗ | |
| Rajeev Shah | 11.1% | 13D | Sep 29, 2025 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 10.1% | 13D | Sep 29, 2025 | filing ↗ | |
| Rubric Capital Management LP | 8.1% | 13G | May 15, 2026 | filing ↗ | |
| David Rosen | 8.1% | 13G | May 15, 2026 | filing ↗ | |
| James E. Flynn | 7.8% | 13D | Jul 30, 2025 | filing ↗ | |
| Deerfield Management Company, L.P. | 7.8% | 13D | Jul 30, 2025 | filing ↗ | |
| Blackrock, Inc. | 5.3% | 13G | Jul 27, 2026 | filing ↗ | |
| Millennium Management LLC | exited | 13G | Jul 14, 2026 | filing ↗ | |
| Millennium Group Management LLC | exited | 13G | Jul 14, 2026 | filing ↗ | |
| Israel A. Englander | exited | 13G | Jul 14, 2026 | filing ↗ | |
| Integrated CORE Strategies (US) LLC | exited | 13G | Jul 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Eric Karas | $250K | Jun 12, 2026 | filing ↗ |
| Alexander Fitzpatrick | $34K | Jun 12, 2026 | filing ↗ |
| Brian T Dorsey | $190K | Nov 13, 2025 | filing ↗ |
| Chakma Justin | $1.2M | Nov 12, 2025 | filing ↗ |
| Justin Chakma | $267K | Nov 12, 2025 | filing ↗ |
| Kathleen D Scott | $188K | Aug 21, 2025 | filing ↗ |
| Richard E. Lowenthal | $2.1M | Aug 21, 2025 | filing ↗ |
| Tanimoto Sarina | $2.1M | Aug 19, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 6, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 24, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | Mar 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 29, 2025 | filing ↗ |
| New financial obligation (2.03) | Sep 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 29, 2025 | filing ↗ |
| Other events (8.01) | Aug 13, 2025 | filing ↗ |
| Earnings (2.02) | Aug 13, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2025 | filing ↗ |